Substances

Funded by the NIH HEAL Initiative^®

Funded by the NIH HEAL Initiative^®

This study will use a multi-state linked administrative database to compare opioid-related outcomes among Medicaid recipients admitted for treatment of opioid use disorder in outpatient and inpatient (or residential) facilities. Patient and organizational factors predicting higher retention in outpatient treatment for OUD will also be examined. These data will be used to generate hypotheses on how to improve retention in treatment.

NIDA funds a broad portfolio of research addressing drug abuse in the context of the justice system. Drug abuse and crime are highly correlated in both the adult criminal justice system and the juvenile justice system. Estimates suggest that over half of individuals in prison and nearly two thirds of individuals in jails met criteria for drug dependence or misuse. ¹ Among adolescents involved in serious offenses, substance dependence or misuse is approximately 3-4 times higher than that of the general population of adolescents.

Funded by the NIH HEAL Initiative^®

This project will develop models to predict individual patient’s risk for relapse (or dropout from treatment) when treated with medications for OUD including methadone, buprenorphine, or extended-release depot naltrexone.

The Great Plains Initiative has two primary aims. Aim 1 is to determine community-defined needs for identifying and addressing substance use issues in order to create a Great Plains American Indian substance use research agenda. Such issues may involve a broad range of topics, such as specific substance misuse, barriers to treatment, the role of historical trauma in substance use, mistrust of research, and others as determined through the Community-based participatory research process.

Funded by the NIH HEAL Initiative^®

Funded by the NIH HEAL Initiative^®

Funded by the NIH HEAL Initiative^®

The overall objective of this project is to investigate effective ways to expand access to MOUD in rural areas. Telemedicine (TM) offers an alternative or complementary approach to delivery of MOUD that is particularly attractive for implementation in rural areas. The CTN-0102 Feasibility study aims to examine the feasibility and acceptability of implementing TM in six rural primary care clinics with varying levels of OBOT capacity to inform implementation strategies for future larger randomized control trials.

Substance abuse is associated with a wide spectrum of medical disorders, including infections due to the human immunodeficiency virus (HIV) and the hepatitis C virus (HCV) as well as sexually transmitted infections. Despite the seriousness of this problem, there has not been a systematic investigation of infectious disease services in the substance abuse treatment health care delivery system.

Funded by the NIH HEAL Initiative^®

This study will use mixed methods to study pharmacists’ knowledge of, attitudes about, and intention to provide patient care and services for Screening for substance use, Brief Intervention, and Referral to Treatment (SBIRT) for substance use disorders (SUDs) and Medication treatment for Opioid Use Disorders (MOUD). The findings will inform barriers and facilitators related to pharmacist-provided services and patient care for SBIRT and MOUD. A survey instrument for assessing such barriers and facilitators will be developed.